Boston weighs up unit and plant divestment
This article was originally published in Clinica
Executive Summary
Boston Scientific is exploring the divestment of its fluid management business and two of its operating facilities, as a result of the company's ongoing business strategy review. However, the company has also stated that it would not be selling its endosurgery unit.